Thus, our in vitro and in vivo data confirmed that CDKN2B-AS1 is involved in KIRC progression at least partly through the regulation of NUF2, suggesting that the CDKN2B-AS1/NUF2 axis is important for the regulation of KIRC tumor growth and metastasis. This evidence concerns the gene CDKN2B and neoplasm.